Contact Us
Global Autacoids And Related Drug Market Report 2025

Autacoids And Related Drug Global Market Report 2025 - By Type (Histamines, Prostaglandins, Leukotrienes, Serotonin, Bradykinin), By Administration (Oral, Injectable, Topical, Intranasal, Inhalation), By Application (Cardiovascular Disorders, Inflammatory Diseases, Respiratory Disorders, Allergies, Gastrointestinal Disorders), By End User (Hospitals, Clinics, Homecare, Pharmacies) - Market Size, Trends, And Global Forecast 2025-2034

Autacoids And Related Drug Global Market Report 2025

Report Price : $4490.00 | Pages : 200 | Published : June 2025 | Delivery Time: 2-3 business days Info | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Autacoids And Related Drug Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Autacoids And Related Drug Market?

Autacoids and related drugs are biologically active substances produced by the body that act locally to regulate physiological functions, typically within a specific tissue or organ. They are involved in inflammation, smooth muscle contraction, immune responses, and blood flow regulation. Autacoids exert their effects by binding specific receptors on target cells, initiating signaling pathways that influence cellular activity.

The main types of autacoids and related drug include histamines, prostaglandins, leukotrienes, serotonin, and bradykinin. Histamines are chemicals released during allergic reactions that cause symptoms such as itching, swelling, and increased stomach acid. They are targeted in treatments for allergies and acid-related conditions. Drugs targeting these autacoids can be administered through various routes, including oral, injectable, topical, intranasal, and inhalation. These treatments are used for a variety of applications, such as cardiovascular disorders, inflammatory diseases, respiratory disorders, allergies, and gastrointestinal conditions. The primary end-users of these treatments include hospitals, clinics, homecare settings, and pharmacies.

Autacoids And Related Drug Market Size and growth rate 2025 to 2029: Graph

What Is The Autacoids And Related Drug Market Size 2025 And Growth Rate?

The autacoids and related drug market size has grown strongly in recent years. It will grow from $50.15 billion in 2024 to $53.32 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to increasing prevalence of inflammatory diseases, rising use of prostaglandins in obstetrics, widespread prescription of antihistamines, expanding applications of serotonin agonists, and higher demand for migraine relief medications.

What Is The Autacoids And Related Drug Market Growth Forecast?

The autacoids and related drug market size is expected to see strong growth in the next few years. It will grow to $67.64 billion in 2029 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to rising geriatric population, growing prevalence of chronic respiratory diseases, personalized medicine adoption, expanding healthcare access in emerging economies, and rising incidence of cardiovascular disorders. Major trends in the forecast period include integration of artificial intelligence in drug discovery, development of dual-action autacoid drugs, adoption of biosimilars for autacoid treatments, growth in self-medication and otc products, and use of nanotechnology in drug formulation.

How Is The Autacoids And Related Drug Market Segmented?

The autacoids and related drug market covered in this report is segmented –

1) By Type: Histamines, Prostaglandins, Leukotrienes, Serotonin, Bradykinin

2) By Administration: Oral, Injectable, Topical, Intranasal, Inhalation

3) By Application: Cardiovascular Disorders, Inflammatory Diseases, Respiratory Disorders, Allergies, Gastrointestinal Disorders

4) By End User: Hospitals, Clinics, Homecare, Pharmacies

Subsegments:

1) By Histamines: H1 Receptor Antagonists, H2 Receptor Antagonists, H3 Receptor Antagonists, H4 Receptor Antagonists, Histamine Agonists

2) By Prostaglandins: Prostaglandin E1 (PGE1) Analogs, Prostaglandin E2 (PGE2) Analogs, Prostaglandin F2a (PGF2a) Analogs, Prostaglandin I2 (PGI2) Analogs, Prostaglandin D2 (PGD2) Analogs

3) By Leukotrienes: Leukotriene Receptor Antagonists (LTRAs), 5-Lipoxygenase Inhibitors, Leukotriene Synthesis Inhibitors

4) By Serotonin: 5-HT1 Receptor Agonists, 5-HT2 Receptor Antagonists, 5-HT3 Receptor Antagonists, 5-HT4 Receptor Agonists, 5-HT6 And 5-HT7 Modulators

5) By Bradykinin: Bradykinin B1 Receptor Antagonists, Bradykinin B2 Receptor Antagonists, Bradykinin Receptor Agonists

What Is Driving The Autacoids And Related Drug Market? Increasing Prevalence Of Cardiovascular Diseases Is Fueling The Market Growth Due To Rising Demand For Vascular And Anti-Inflammatory Therapies

The increasing prevalence of cardiovascular diseases is expected to propel the growth of autacoids and related drugs market going forward. Cardiovascular diseases refer to a group of disorders affecting the heart and blood vessels, including conditions such as coronary heart disease, heart failure, stroke, and hypertension. The increasing prevalence of cardiovascular diseases is primarily attributed to poor diet, as the excessive consumption of saturated fats, trans fats, added sugars, and sodium contributes to high blood pressure, obesity, and elevated cholesterol levels, all of which are major risk factors for heart-related conditions. Autacoids and related drugs enhance cardiovascular health by modulating vascular tone and inflammation, crucial in conditions such as hypertension and heart failure. The agents targeting pathways involving nitric oxide, endothelin, and prostacyclin help restore endothelial function, promoting vasodilation and reducing vascular resistance. For instance, in December 2023, according to the Australian Institute of Health and Welfare, an Australia-based government agency, doctor-certified deaths due to coronary heart disease (CHD) in Australia increased from 14,100 in 2021 to 14,900 in 2022. Therefore, the increasing prevalence of cardiovascular diseases is driving the growth of the autacoids and related drugs market.

Who Are The Major Players In The Global Autacoids And Related Drug Market?

Major companies operating in the autacoids and related drug market are Sanofi S.A., Fresenius SE & Co. KGaA, Dr. Reddy's Laboratories Limited, EUROAPI S.A., Pfizer CentreOne, Cayman Chemical Company, Tokyo Chemical Industry Co. Ltd., Avanti Polar Lipids Inc., Kyowa Pharma Chemical Co. Ltd., Nicox S.A., Glentham Life Sciences Ltd., LGM Pharma Inc., chemBlink Inc., ZellBio GmbH, AquigenBio LLC, BOC Sciences Inc., Yarrow Chem Products Pvt. Ltd., LEBSA S.A., VDK NaturaSyn S.A., Enzo Life Sciences Inc.

What Are The Key Trends Of The Global Autacoids And Related Drug Market? Improving Access To Allergy Medications Through OTC Availability

Major companies operating in autacoids and related drugs are focusing on developing innovative products, such as antihistamines, to enhance therapeutic efficacy, reduce side effects, and address emerging allergic and inflammatory conditions with greater precision and safety. Antihistamines are medications that block the effects of histamine, a chemical released by your immune system during an allergic reaction.  For instance, in March 2023, Tiefenbacher Pharmaceuticals, a Germany-based pharmaceuticals company, launched  Bilastine as an over-the-counter (OTC) medicine in Germany, marking a significant step in improving access to effective allergy treatments. The 20 mg blasting tablets offer a non-sedating, second-generation antihistamine solution for patients suffering from allergic symptoms such as hay fever and urticaria.

What Are Latest Mergers And Acquisitions In The Autacoids And Related Drug Market? Incyte Completes Acquisition Of Escient Pharmaceuticals To Expand Immunology Portfolio

In May 2024, Incyte Corporation, a US-based biopharmaceutical company, acquired Escient Pharmaceuticals Inc. for approximately $750 million. With this acquisition, Incyte aims to expand its immunology portfolio and accelerate the development of novel treatments for pruritus and other inflammatory disorders by integrating Escient Pharmaceuticals' innovative pipeline of first-in-class, small molecule therapeutics targeting Mas-related G protein-coupled receptors (MRGPRs). Escient Pharmaceuticals Inc. is a US-based biotechnology company developing novel therapeutics targeting autacoid-related pathways.

What Is The Regional Outlook For The Global Autacoids And Related Drug Market?

North America was the largest region in the autacoids and related drug market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the autacoids and related drug market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the autacoids and related drug market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Autacoids And Related Drug Market?

The autacoids and related drug market consists of sales of biogenic amines, polypeptide autacoids, lipid-derived autacoids, and leukotrienes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Autacoids And Related Drug Industry?

The autacoids and related drug market research report is one of a series of new reports from The Business Research Company that provides autacoids and related drug market statistics, including the autacoids and related drug industry global market size, regional shares, competitors with the autacoids and related drug market share, detailed autacoids and related drug market segments, market trends, and opportunities, and any further data you may need to thrive in the autacoids and related drug industry. This autacoids and related drug market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Autacoids And Related Drug Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 $53.32 billion
Revenue Forecast In 2034 $67.64 billion
Growth Rate CAGR of 6.1% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The autacoids and related drug market covered in this report is segmented –
1) By Type: Histamines, Prostaglandins, Leukotrienes, Serotonin, Bradykinin
2) By Administration: Oral, Injectable, Topical, Intranasal, Inhalation
3) By Application: Cardiovascular Disorders, Inflammatory Diseases, Respiratory Disorders, Allergies, Gastrointestinal Disorders
4) By End User: Hospitals, Clinics, Homecare, Pharmacies Subsegments:
1) By Histamines: H1 Receptor Antagonists, H2 Receptor Antagonists, H3 Receptor Antagonists, H4 Receptor Antagonists, Histamine Agonists
2) By Prostaglandins: Prostaglandin E1 (PGE
1) Analogs, Prostaglandin E2 (PGE
2) Analogs, Prostaglandin F2a (PGF2a) Analogs, Prostaglandin I2 (PGI
2) Analogs, Prostaglandin D2 (PGD
2) Analogs
3) By Leukotrienes: Leukotriene Receptor Antagonists (LTRAs), 5-Lipoxygenase Inhibitors, Leukotriene Synthesis Inhibitors
4) By Serotonin: 5-HT1 Receptor Agonists, 5-HT2 Receptor Antagonists, 5-HT3 Receptor Antagonists, 5-HT4 Receptor Agonists, 5-HT6 And 5-HT7 Modulators
5) By Bradykinin: Bradykinin B1 Receptor Antagonists, Bradykinin B2 Receptor Antagonists, Bradykinin Receptor Agonists
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Sanofi S.A., Fresenius SE & Co. KGaA, Dr. Reddy's Laboratories Limited, EUROAPI S.A., Pfizer CentreOne, Cayman Chemical Company, Tokyo Chemical Industry Co. Ltd., Avanti Polar Lipids Inc., Kyowa Pharma Chemical Co. Ltd., Nicox S.A., Glentham Life Sciences Ltd., LGM Pharma Inc., chemBlink Inc., ZellBio GmbH, AquigenBio LLC, BOC Sciences Inc., Yarrow Chem Products Pvt. Ltd., LEBSA S.A., VDK NaturaSyn S.A., Enzo Life Sciences Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Autacoids And Related Drug Market Characteristics

    3. Autacoids And Related Drug Market Trends And Strategies

    4. Autacoids And Related Drug Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

    5. Global Autacoids And Related Drug Growth Analysis And Strategic Analysis Framework

    5.1. Global Autacoids And Related Drug PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Autacoids And Related Drug Market Growth Rate Analysis

    5.4. Global Autacoids And Related Drug Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Autacoids And Related Drug Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Autacoids And Related Drug Total Addressable Market (TAM)

    6. Autacoids And Related Drug Market Segmentation

    6.1. Global Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Histamines

    Prostaglandins

    Leukotrienes

    Serotonin

    Bradykinin

    6.2. Global Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Oral

    Injectable

    Topical

    Intranasal

    Inhalation

    6.3. Global Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Cardiovascular Disorders

    Inflammatory Diseases

    Respiratory Disorders

    Allergies

    Gastrointestinal Disorders

    6.4. Global Autacoids And Related Drug Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hospitals

    Clinics

    Homecare

    Pharmacies

    6.5. Global Autacoids And Related Drug Market, Sub-Segmentation Of Histamines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    H1 Receptor Antagonists

    H2 Receptor Antagonists

    H3 Receptor Antagonists

    H4 Receptor Antagonists

    Histamine Agonists

    6.6. Global Autacoids And Related Drug Market, Sub-Segmentation Of Prostaglandins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Prostaglandin E1 (PGE1) Analogs

    Prostaglandin E2 (PGE2) Analogs

    Prostaglandin F2a (PGF2a) Analogs

    Prostaglandin I2 (PGI2) Analogs

    Prostaglandin D2 (PGD2) Analogs

    6.7. Global Autacoids And Related Drug Market, Sub-Segmentation Of Leukotrienes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Leukotriene Receptor Antagonists (LTRAs)

    5-Lipoxygenase Inhibitors

    Leukotriene Synthesis Inhibitors

    6.8. Global Autacoids And Related Drug Market, Sub-Segmentation Of Serotonin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    5-HT1 Receptor Agonists

    5-HT2 Receptor Antagonists

    5-HT3 Receptor Antagonists

    5-HT4 Receptor Agonists

    5-HT6 And 5-HT7 Modulators

    6.9. Global Autacoids And Related Drug Market, Sub-Segmentation Of Bradykinin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Bradykinin B1 Receptor Antagonists

    Bradykinin B2 Receptor Antagonists

    Bradykinin Receptor Agonists

    7. Autacoids And Related Drug Market Regional And Country Analysis

    7.1. Global Autacoids And Related Drug Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Autacoids And Related Drug Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Autacoids And Related Drug Market

    8.1. Asia-Pacific Autacoids And Related Drug Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Autacoids And Related Drug Market

    9.1. China Autacoids And Related Drug Market Overview

    9.2. China Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Autacoids And Related Drug Market

    10.1. India Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Autacoids And Related Drug Market

    11.1. Japan Autacoids And Related Drug Market Overview

    11.2. Japan Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Autacoids And Related Drug Market

    12.1. Australia Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Autacoids And Related Drug Market

    13.1. Indonesia Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Autacoids And Related Drug Market

    14.1. South Korea Autacoids And Related Drug Market Overview

    14.2. South Korea Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Autacoids And Related Drug Market

    15.1. Western Europe Autacoids And Related Drug Market Overview

    15.2. Western Europe Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Autacoids And Related Drug Market

    16.1. UK Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Autacoids And Related Drug Market

    17.1. Germany Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Autacoids And Related Drug Market

    18.1. France Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Autacoids And Related Drug Market

    19.1. Italy Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Autacoids And Related Drug Market

    20.1. Spain Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Autacoids And Related Drug Market

    21.1. Eastern Europe Autacoids And Related Drug Market Overview

    21.2. Eastern Europe Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Autacoids And Related Drug Market

    22.1. Russia Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Autacoids And Related Drug Market

    23.1. North America Autacoids And Related Drug Market Overview

    23.2. North America Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Autacoids And Related Drug Market

    24.1. USA Autacoids And Related Drug Market Overview

    24.2. USA Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Autacoids And Related Drug Market

    25.1. Canada Autacoids And Related Drug Market Overview

    25.2. Canada Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Autacoids And Related Drug Market

    26.1. South America Autacoids And Related Drug Market Overview

    26.2. South America Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Autacoids And Related Drug Market

    27.1. Brazil Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Autacoids And Related Drug Market

    28.1. Middle East Autacoids And Related Drug Market Overview

    28.2. Middle East Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Autacoids And Related Drug Market

    29.1. Africa Autacoids And Related Drug Market Overview

    29.2. Africa Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Autacoids And Related Drug Market Competitive Landscape And Company Profiles

    30.1. Autacoids And Related Drug Market Competitive Landscape

    30.2. Autacoids And Related Drug Market Company Profiles

    30.2.1. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. Fresenius SE & Co. KGaA Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. Dr. Reddy's Laboratories Limited Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. EUROAPI S.A. Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. Pfizer CentreOne Overview, Products and Services, Strategy and Financial Analysis

    31. Autacoids And Related Drug Market Other Major And Innovative Companies

    31.1. Cayman Chemical Company

    31.2. Tokyo Chemical Industry Co. Ltd.

    31.3. Avanti Polar Lipids Inc.

    31.4. Kyowa Pharma Chemical Co. Ltd.

    31.5. Nicox S.A.

    31.6. Glentham Life Sciences Ltd.

    31.7. LGM Pharma Inc.

    31.8. chemBlink Inc.

    31.9. ZellBio GmbH

    31.10. AquigenBio LLC

    31.11. BOC Sciences Inc.

    31.12. Yarrow Chem Products Pvt. Ltd.

    31.13. LEBSA S.A.

    31.14. VDK NaturaSyn S.A.

    31.15. Enzo Life Sciences Inc.

    32. Global Autacoids And Related Drug Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Autacoids And Related Drug Market

    34. Recent Developments In The Autacoids And Related Drug Market

    35. Autacoids And Related Drug Market High Potential Countries, Segments and Strategies

    35.1 Autacoids And Related Drug Market In 2029 - Countries Offering Most New Opportunities

    35.2 Autacoids And Related Drug Market In 2029 - Segments Offering Most New Opportunities

    35.3 Autacoids And Related Drug Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Autacoids And Related Drug Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Autacoids And Related Drug Market, Sub-Segmentation Of Histamines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Autacoids And Related Drug Market, Sub-Segmentation Of Prostaglandins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Autacoids And Related Drug Market, Sub-Segmentation Of Leukotrienes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Autacoids And Related Drug Market, Sub-Segmentation Of Serotonin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Autacoids And Related Drug Market, Sub-Segmentation Of Bradykinin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Autacoids And Related Drug Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Autacoids And Related Drug Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Asia-Pacific, Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: China, Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: India, Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Japan, Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Australia, Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Indonesia, Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: South Korea, Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Western Europe, Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: UK, Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Germany, Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: France, Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Italy, Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Spain, Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Eastern Europe, Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Russia, Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: North America, Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: USA, Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Canada, Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: South America, Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Brazil, Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Middle East, Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Africa, Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Sanofi S.A. Financial Performance
  • Table 81: Fresenius SE & Co. KGaA Financial Performance
  • Table 82: Dr. Reddy's Laboratories Limited Financial Performance
  • Table 83: EUROAPI S.A. Financial Performance
  • Table 84: Pfizer CentreOne Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Autacoids And Related Drug Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Autacoids And Related Drug Market, Sub-Segmentation Of Histamines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Autacoids And Related Drug Market, Sub-Segmentation Of Prostaglandins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Autacoids And Related Drug Market, Sub-Segmentation Of Leukotrienes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Autacoids And Related Drug Market, Sub-Segmentation Of Serotonin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Autacoids And Related Drug Market, Sub-Segmentation Of Bradykinin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Autacoids And Related Drug Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Autacoids And Related Drug Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Asia-Pacific, Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: China, Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: India, Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Japan, Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Australia, Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Indonesia, Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: South Korea, Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Western Europe, Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: UK, Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Germany, Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: France, Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Italy, Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Spain, Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Eastern Europe, Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Russia, Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: North America, Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: USA, Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Canada, Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: South America, Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Brazil, Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Middle East, Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Africa, Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Sanofi S.A. Financial Performance
  • Figure 81: Fresenius SE & Co. KGaA Financial Performance
  • Figure 82: Dr. Reddy's Laboratories Limited Financial Performance
  • Figure 83: EUROAPI S.A. Financial Performance
  • Figure 84: Pfizer CentreOne Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the Autacoids And Related Drug market?

Autacoids and related drugs are biologically active substances produced by the body that act locally to regulate physiological functions, typically within a specific tissue or organ. They are involved in inflammation, smooth muscle contraction, immune responses, and blood flow regulation. Autacoids exert their effects by binding specific receptors on target cells, initiating signaling pathways that influence cellular activity. For further insights on the Autacoids And Related Drug market, request a sample here

How will the Autacoids And Related Drug market drivers and restraints affect the market dynamics? What forces will shape the Autacoids And Related Drug industry going forward?

The Autacoids And Related Drug market major growth driver - Increasing Prevalence Of Cardiovascular Diseases Is Fueling The Market Growth Due To Rising Demand For Vascular And Anti-Inflammatory Therapies. For further insights on the Autacoids And Related Drug market, request a sample here

What is the forecast market size or the forecast market value of the Autacoids And Related Drug market?

The Autacoids And Related Drug market size has grown strongly in recent years. The autacoids and related drug market size has grown strongly in recent years. It will grow from $50.15 billion in 2024 to $53.32 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to increasing prevalence of inflammatory diseases, rising use of prostaglandins in obstetrics, widespread prescription of antihistamines, expanding applications of serotonin agonists, and higher demand for migraine relief medications. The autacoids and related drug market size is expected to see strong growth in the next few years. It will grow to $67.64 billion in 2029 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to rising geriatric population, growing prevalence of chronic respiratory diseases, personalized medicine adoption, expanding healthcare access in emerging economies, and rising incidence of cardiovascular disorders. Major trends in the forecast period include integration of artificial intelligence in drug discovery, development of dual-action autacoid drugs, adoption of biosimilars for autacoid treatments, growth in self-medication and otc products, and use of nanotechnology in drug formulation. For further insights on the Autacoids And Related Drug market, request a sample here

How is the Autacoids And Related Drug market segmented?

The autacoids and related drug market covered in this report is segmented –
1) By Type: Histamines, Prostaglandins, Leukotrienes, Serotonin, Bradykinin
2) By Administration: Oral, Injectable, Topical, Intranasal, Inhalation
3) By Application: Cardiovascular Disorders, Inflammatory Diseases, Respiratory Disorders, Allergies, Gastrointestinal Disorders
4) By End User: Hospitals, Clinics, Homecare, Pharmacies
Subsegments:
1) By Histamines: H1 Receptor Antagonists, H2 Receptor Antagonists, H3 Receptor Antagonists, H4 Receptor Antagonists, Histamine Agonists
2) By Prostaglandins: Prostaglandin E1 (PGE1) Analogs, Prostaglandin E2 (PGE2) Analogs, Prostaglandin F2a (PGF2a) Analogs, Prostaglandin I2 (PGI2) Analogs, Prostaglandin D2 (PGD2) Analogs
3) By Leukotrienes: Leukotriene Receptor Antagonists (LTRAs), 5-Lipoxygenase Inhibitors, Leukotriene Synthesis Inhibitors
4) By Serotonin: 5-HT1 Receptor Agonists, 5-HT2 Receptor Antagonists, 5-HT3 Receptor Antagonists, 5-HT4 Receptor Agonists, 5-HT6 And 5-HT7 Modulators
5) By Bradykinin: Bradykinin B1 Receptor Antagonists, Bradykinin B2 Receptor Antagonists, Bradykinin Receptor Agonists For further insights on the Autacoids And Related Drug market,
request a sample here

Which region has the largest share of the Autacoids And Related Drug market? What are the other regions covered in the report?

North America was the largest region in the autacoids and related drug market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the autacoids and related drug market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Autacoids And Related Drug market, request a sample here.

Who are the major players in the Autacoids And Related Drug market?

Major companies operating in the autacoids and related drug market are Sanofi S.A., Fresenius SE & Co. KGaA, Dr. Reddy's Laboratories Limited, EUROAPI S.A., Pfizer CentreOne, Cayman Chemical Company, Tokyo Chemical Industry Co. Ltd., Avanti Polar Lipids Inc., Kyowa Pharma Chemical Co. Ltd., Nicox S.A., Glentham Life Sciences Ltd., LGM Pharma Inc., chemBlink Inc., ZellBio GmbH, AquigenBio LLC, BOC Sciences Inc., Yarrow Chem Products Pvt. Ltd., LEBSA S.A., VDK NaturaSyn S.A., Enzo Life Sciences Inc. . For further insights on the Autacoids And Related Drug market, request a sample here.

What are the key trends in the Autacoids And Related Drug market?

Major trends in the Autacoids And Related Drug market include Improving Access To Allergy Medications Through OTC Availability. For further insights on the Autacoids And Related Drug market, request a sample here.

What are the major opportunities in the Autacoids And Related Drug market? What are the strategies for the Autacoids And Related Drug market?

For detailed insights on the major opportunities and strategies in the Autacoids And Related Drug market, request a sample here.

How does the Autacoids And Related Drug market relate to the overall economy and other similar markets?

For detailed insights on Autacoids And Related Drug's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Autacoids And Related Drug industry?

For detailed insights on the mergers and acquisitions in the Autacoids And Related Drug industry, request a sample here.

What are the key dynamics influencing the Autacoids And Related Drug market growth? SWOT analysis of the Autacoids And Related Drug market.

For detailed insights on the key dynamics influencing the Autacoids And Related Drug market growth and SWOT analysis of the Autacoids And Related Drug industry, request a sample here.